Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06933173
Recruiting
RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis
Not applicable · Canada · 2 sites
Registry update: 9 Sept 2026
NCT06895070
Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Not applicable · United States · 14 sites
Registry update: 18 Mar 2026
NCT07186621
Recruiting
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
Phase 3 · China · 1 site
Registry update: 22 Sept 2025
NCT07105631
Recruiting
Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal Cancer Who Received the Zidovudine Combination Regimen in the Real World
Not applicable · China · 1 site
Registry update: 6 Aug 2025
NCT06838676
Recruiting
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Phase 2 · Australia, Canada, Germany, New Zealand, United States · 20 sites
Registry update: 23 Oct 2026
NCT07070726
Recruiting
UNTOLD Ovarian Cancer Unmet Needs Survey
Not applicable · United States · 1 site
Registry update: 8 Jul 2026
NCT06757764
Recruiting
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
Phase 4 · South Korea · 24 sites
Registry update: 27 Mar 2026
NCT06793709
Recruiting
A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
Not applicable · Japan · 1 site
Registry update: 27 Feb 2026
NCT07088380
Recruiting
Ketamine Augmentation of ECT in Treatment-Resistant Depression
Phase 3 · Italy · 1 site
Registry update: 11 May 2026
NCT07168772
Recruiting
The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis
Not applicable · Spain · 1 site
Registry update: 7 Aug 2026
2023-508525-27-00
Recruiting
A multiarm, randomized, open label Clinical study comparing AntiatheroSClerotic efficacy of selected Antidiabetic agents in patients with coronary artery disease and preDiabetES. A randomised clinical trial (CASCADES)
Phase 4 · Poland · 1 site
Registry update: 27 Aug 2025
NCT07386158
Recruiting
Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC
Phase 2 · China · 1 site
Registry update: 4 Feb 2026
NCT07254572
Recruiting
Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
Phase 4 · Poland · 1 site
Registry update: 28 Nov 2025
NCT06769490
Recruiting
Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
Phase 1 · United States · 1 site
Registry update: 18 Sept 2026
NCT06649227
Recruiting
Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19
Phase 1 · France · 1 site
Registry update: 5 Dec 2025
NCT07134842
Recruiting
A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
Phase 1 · United Kingdom · 1 site
Registry update: 9 Apr 2026
NCT06973902
Recruiting
The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HF
Not applicable · Italy · 13 sites
Registry update: 29 Jul 2025
NCT07097935
Recruiting
Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma
Phase 1/2 · China · 1 site
Registry update: 1 Aug 2025
NCT06794775
Recruiting
SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma
Phase 3 · Sweden · 3 sites
Registry update: 12 Dec 2025
NCT06699849
Recruiting
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Phase 2 · Belgium, Germany, Spain, France, United Kingdom, Greece, Italy, Netherlands, United States · 58 sites
Registry update: 8 Oct 2026
Conflicting statuses (not updated in the registry for 1 month)

Ordered by registry start date. Freshness and sponsorship never change the order.